Royalty Pharma indicated at a Morgan Stanley conference that its growth is broadening beyond royalties.
Further verified details were not immediately available.
Royalty Pharma says growth expanding beyond royalties at Morgan Stanley conference
Royalty Pharma told attendees at a Morgan Stanley conference that its growth is extending beyond its core royalty business.
PA
Priya Anand · Equities & Earnings Desk · 14 Sept 2026 · 19:55 · 1 min read
This article was produced with AI assistance and edited by a Finance Review Daily journalist.
ADVERTISEMENT
PA
Written by
Priya Anand
Equities & Earnings Desk
Priya covers listed equities and corporate earnings, reading quarterly results and guidance for what they signal about sector health and forward valuations.
More from Priya Anand →
